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Review article
Yaws
Michael Marks1,2, Dornubari Lebari3, Anthony W Solomon1,2
and Stephen P Higgins3
Abstract
Yaws is a non-venereal endemic treponemal infection caused by Treponema pallidum sub-species pertenue, a spirochaete
bacterium closely related to Treponema pallidum pallidum, the agent of venereal syphilis. Yaws is a chronic, relapsing
disease predominantly affecting children living in certain tropical regions. It spreads by skin-to-skin contact and, like
syphilis, occurs in distinct clinical stages. It causes lesions of the skin, mucous membranes and bones which, without
treatment, can become chronic and destructive. Treponema pallidum pertenue, like its sexually transmitted counterpart, is
exquisitely sensitive to penicillin. Infection with yaws or syphilis results in reactive treponemal serology and there is no
widely available test to distinguish between these infections. Thus, migration of people from yaws-endemic areas to
developed countries may present clinicians with diagnostic dilemmas. We review the epidemiology, clinical presentation
and treatment of yaws.
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Yaws
Yaws is a non-venereal endemic treponemal infection
caused by Treponema pallidum sub-species pertenue,1 a
bacterium closely related to Treponema pallidum palli-
dum, the agent of venereal syphilis. Yaws predomin-
antly aﬀects children living in tropical regions of the
world. It causes lesions of the skin, mucous membranes
and bones which, without treatment, can become
chronic and destructive. There is no widely available
test to distinguish yaws from syphilis. Thus, migration
of people from yaws-endemic areas to developed coun-
tries may present clinicians with diagnostic dilemmas.
The other endemic treponemal infections are bejel
(endemic syphilis) caused by Treponema pallidum ende-
micum and pinta caused by Treponema carateum.
Epidemiology
Yaws is currently thought to be endemic in at least 12
countries2,3 (Table 1). The number of notiﬁed yaws
cases is almost certainly an underestimate of true dis-
ease incidence. Yaws primarily aﬀects children living in
poor, densely populated rural areas. The concentration
of yaws in warm, humid climates is thought to be
explained by the sensitivity of T p pertenue to relative
cool and dryness and may explain why skin lesions are
seen more often in the rainy season.4
In the 1950s it was estimated that 50 million people
were infected with yaws. The World Health
Organization (WHO) tried to eliminate the disease
through a mass treatment campaign using benzylpeni-
cillin.2,5 Consequently, the number of infections world-
wide dropped signiﬁcantly but yaws then fell oﬀ the
public health agenda. The next 30 years saw a resur-
gence of cases and the disease is, again, a public health
problem in Africa,6 South-East Asia, the Paciﬁc7,8 and
South America.9 The WHO estimates that 2.5 million
individuals may currently be infected.2 A failure to
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identify contacts of infected individuals, inadequate
treatment of latent yaws as well as a failure to integrate
control eﬀorts into primary health care are thought to
have led to the eventual failure of the WHO elimination
strategy.5
Transmission
Bacteria from infectious lesions enter via a breach in
the skin. Lesions of early yaws are most infectious as
they carry a higher bacterial load, whilst late yaws
lesions are not infectious. It is estimated that infectivity
lasts for 12–18 months after primary infection1 but
relapsing disease can extend this period (see ‘latency’
below). It has been postulated that infection might be
spread by ﬂies10 but there is no evidence to support this
mode of transmission in humans. Transplacental
spread of T p pertenue is said not to occur, but this
view is disputed.11
Bacteriology
T p pertenue is a Gram-negative spirochaete which
cannot be cultured in vitro.1 Five strains have been
cultured in rabbits and golden hamsters.12 The organ-
ism is closely related to T p pallidum with a genome that
diﬀers by approximately 0.2%. These diﬀerences are
restricted to a small number of genes including tpr
and TP0136. The role of these genes is uncertain but
they have been implicated in pathogenesis.12 The phylo-
genetic relationship of yaws and syphilis remains
unclear and there is evidence that recombination
between the two organisms can occur.13
Clinical presentation
The clinical presentation of yaws bears similarities to
that of syphilis (Table 2). Like syphilis, yaws can be
staged as early (primary and secondary) and late, or
tertiary. Though clinically useful, this classiﬁcation is
artiﬁcial and patients may present with a mixture of
clinical signs.
Primary yaws
A papule appears at the inoculation site after about 21
days (range 9–90).1,10 This ‘Mother Yaw’ may evolve
either into an exudative papilloma, 2–5 cm in size or
degenerate to form a single, non-tender ulcer
(Figures 1–3) covered by a yellow crust. The legs and
ankles are the commonest sites aﬀected, but lesions may
occur on the face, buttocks, arms or hands.14 ‘Split-
papules’ may occur at the angle of the mouth.1
Regional lymphadenopathy is common. In contrast to
syphilis, genital lesions are rare. Primary lesions are
indolent and take 3–6 months to heal, more often leav-
ing a pigmented scar.15 As in syphilis,16 the primary
lesion is still present when signs of secondary yaws
develop in about 9–15% of patients.17
Secondary yaws
Haematogenous and lymphatic spread of treponemes
produces secondary lesions, most commonly one to
two months (but up to 24 months) after the primary
lesion. General malaise and lymphadenopathy may
occur. The most ﬂorid manifestations of secondary
yaws occur in skin and bone.14
Skin
The rash begins as pinhead-size papules, which develop
a pustular or crusted appearance and may persist for
weeks. If the crust is removed a raspberry-like appear-
ance may be revealed. Sometimes papules enlarge and
coalesce into cauliﬂower-like lesions, most frequently
on the face, trunk, genitalia and buttocks. Scaly mac-
ules may be seen (Figures 4 and 5). Lesions in warm,
moist areas may resemble condylomata lata of syphilis.
The skin lesions of early yaws are often itchy and the
Koebner phenomenon has been observed. Mixed papu-
lar and macular lesions are often seen in individual
patients. Secondary skin lesions may heal even without
treatment, with or without scarring.
Squamous macular or plantar yaws can resemble
secondary syphilis.1 Lesions on the soles of the feet
may become hyperkeratotic, cracked, discoloured or
secondarily infected. This can result in pain and a
crab-like gait.18 Mucous membrane involvement, most
Table 1. Countries in which yaws is currently endemic.
Country Local name
Benin Not Known
Cameroon Not Known
Central African Republic Not Known
Democratic Republic
of the Congo
Not Known
Congo Not Known
Coˆte d’Ivoire* Goundou
Ghana Gyator
Togo Gbodo, Gbodokui,
Indonesia Frambusia
Timor-Leste Not Known
Papua New Guinea Not Known
Solomon Islands Yaws
Vanuatu  50 vatu soa
 bigfella soa
*Endemic status unclear.
2 International Journal of STD & AIDS 0(0)
 at London School of Hygiene and Tropical Med on April 1, 2015std.sagepub.comDownloaded from 
XML Template (2014) [3.9.2014–7:01pm] [1–8]
//blrnas3/cenpro/ApplicationFiles/Journals/SAGE/3B2/STDJ/Vol00000/140160/APPFile/SG-STDJ140160.3d (STD) [PREPRINTER stage]
Table 2. Comparison of clinical features and timing of yaws and syphilis.
Syphilis Yaws
Primary Incubation 9–90 days Incubation 10–90 days
Morphology Chancre Usually solitary,
often multiple.
Non-tender.
Scarring very unusual.
Morphology Mother yaw Usually solitary.
Non-tender.
Scarring usual.
Site Ano-genital Site Legs, ankles
Secondary Incubation Weeks-24 months Incubation Weeks-24 months
Clinical presentation Skin rash
Lymphadenopathy
Mucosal lesions
Clinical presentation Arthralgia
Malaise
Skin
lesions
Polyosteitis of fingers, feet
or long bones
Latency Yes Yes
Infectious relapses Commonest within the first two years,
rarely thereafter
Up to 5 years,
Rarely up to 10 years.
Tertiary Clinical Clinical
Cardiovascular (10%) Decades ??Cardiovascular
5þ years
Neurosyphilis (10%) Weeks (meningitis,
cranial neuritis)
Decades:tabes, GPI
??Neuroyaws
Gummata 10–15 years Gummatous nodules.
Scarring, contractures.
Gangosa. Tibial bowing.
Goundou
Congenital
infection
Yes No evidence
Figure 2. Ulcer of primary yaws. Copyright Michael Marks.
Figure 1. Ulcer of primary yaws. Copyright Michael Marks.
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commonly nasal, was reported in less than 0.5% of
cases in American Samoa.19
There is some evidence that the manifestations of
yaws in the modern era are less ﬂorid than previously
reported. It has been postulated that use of penicillins
to treat other conditions may be responsible for this.
The diﬀerential diagnosis of yaws lesions is wide and
includes syphilis, leishmaniasis, leprosy and Buruli
ulcer, as well as non-infectious causes. Discussion
with a physician with expertise in tropical medicine is
recommended as the diﬀerential diagnosis and choice of
investigations will vary depending on the patient’s
country of origin.
Bones
Secondary yaws typically causes osteoperiostitis of mul-
tiple bones. Involvement of long bones may cause noc-
turnal pain and visible periosteal thickening (Figures 6
and 7). Involvement of the proximal phalanges of the
ﬁngers manifests as polydactylitis. This contrasts with
late yaws in which mono-dactylitis is typical. One study
from Papua New Guinea14 reported joint pains in 75%
of children with secondary yaws.
Latent yaws
Individuals with latent yaws have reactive serological
tests but no clinical signs. It is not known how many
patients are infected without developing clinical dis-
ease. Patients with primary and secondary yaws may
pass into a period of latency after resolution of clinical
signs. As in syphilis, infectious relapses can occur, most
commonly up to ﬁve years (rarely up to 10 years) after
infection.1,20 Relapsing lesions tend to occur around the
axillae, anus and mouth.
Figure 4. Secondary yaws: multiple small ulcerative lesions.
Copyright Michael Marks.
Figure 5. Secondary yaws: maculo-papular lesions with scaling.
Copyright Oriol Mitja`. Figure 6. Secondary yaws: dactylitis. Copyright Oriol Mitja`.
Figure 3. Papilloma of primary yaws. Copyright Oriol Mitja`.
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Tertiary yaws
Tertiary yaws is thought to occur in about 10% of
untreated patients, although its manifestations are rare
in the modern era. The skin is most commonly aﬀected.
Hyperkeratosis of palms and soles and plaques may
occur. Nodules may form near joints and ulcerate, caus-
ing tissue necrosis.4 ‘Sabre tibia’ results from chronic
osteo-periostitis. Gangosa or rhinopharyngitis mutilans
denotes mutilating facial ulceration of the palate and
nasopharynx secondary to osteitis. Goundou was a rare
complication even when yaws was hyperendemic and is
characterised by exostoses of the maxillary bones.21
Cardiovascular yaws
Although the consensus is that yaws does not cause
cardiovascular disease, this view has been challenged.
Post-mortem studies have found evidence of aortitis in
patients with yaws.22 Histologically these lesions are
similar to those found in tertiary syphilis. Despite
these studies, deﬁnitive evidence of cardiovascular dis-
ease in yaws is lacking.
Neurological yaws
The consensus that yaws does not cause neurological
disease1 has also been challenged by studies that found
neuro-ophthalmic23 and CSF abnormalities24 in
patients with yaws. As with cardiovascular disease
deﬁnitive evidence for a causal role of yaws in neuro-
logical disease remains absent.
Yaws and pregnancy
While there is no laboratory evidence that T pallidum
pertenue can cause congenital yaws, there are
anecdotal reports.11 Most were published when sero-
diagnosis relied on non-treponemal tests and before
treponemal IgM testing of neonates was feasible.19
Yaws and HIV
There are no published data on the interaction between
HIV and yaws. It is possible that patients with latent yaws
might develop relapsing disease with increasing immune
damage.25 There are also no data on the impact on other
STIs, although given the low rates of genital lesions and
that the disease predominantly occurs in children it might
be anticipated that any eﬀect would be minimal.
Diagnosis
Syphilis or yaws?
Physicians working in endemic areas usually make a pre-
sumptive diagnosis of yaws based on clinical and epi-
demiological features, with or without conﬁrmatory
blood tests. However, because syphilis and yaws co-exist
in many tropical regions, and serology cannot distinguish
between treponemal sub-species, it may be impossible to
identify with certainty the causative organism. There are
reports of yaws presenting in non-endemic countries.26,27
Laboratory diagnosis
Dark ground microscopy
Spirochaetes were ﬁrst observed in yaws ulcers in 1905,28
the year in which T pallidum pallidum was identiﬁed in a
lymph gland of a patient with syphilis. T pallidum perte-
nue is morphologically identical to T pallidum pallidum.
As T pallidum spp. are only 0.3mm wide and 6–20mm in
length, dark ground microscopy is required for visual-
isation. Samples from primary and secondary yaws
lesions are obtained as described for syphilis.
Polymerase chain reaction
Polymerase chain reaction (PCR) testing of samples can
identify T pallidum but current PCR protocols do not
distinguish between sub-species.14,29 T pallidum perte-
nue has been identiﬁed to sub-species level using real-
time PCR and DNA sequencing in a child from Congo
with a pruritic skin eruption,27 but few clinicians have
access to such techniques.
Serology
While serological tests are the bedrock of yaws diagno-
sis they cannot distinguish between sub-species of
T pallidum.30
Figure 7. Secondary yaws: radiographic evidence of osteoper-
iostitis. Copyright Oriol Mitja`.
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Non-treponemal (cardiolipin) tests
The venereal disease research laboratory (VDRL) and
rapid plasma reagin (RPR) tests use an antigen of car-
diolipin, lecithin and cholesterol. Patient-derived anti-
bodies produced against lipid in the cell surface of
T pallidum react with antigen to cause visible ﬂoccula-
tion. The VDRL is read microscopically whereas the
RPR can be read with the naked eye. Although non-
speciﬁc, VDRL/RPR titres best reﬂect disease activity.
Titres fall after treatment and may become zero, espe-
cially after treatment of early infection.31 RPR titres are
generally higher in primary than secondary yaws.1
Treponemal tests
These include the T pallidum haemagglutination
(TPHA) and the T pallidum particle agglutination
(TPPA) tests. They are more speciﬁc than cardiolipin
tests and usually remain positive after treatment.
Point-of-care tests have proved useful in syphilis and
results of an initial study in Papua New Guinea suggest
they may also be of value in the diagnosis of yaws with
good sensitivity and speciﬁcity.32 Further studies of
these tests in yaws are in progress.
Histology
In early yaws there is marked epidermal hyperplasia
and papillomatosis, often with focal spongiosis.33
Neutrophils accumulate in the epidermis, causing
microabscesses. A dense dermal inﬁltrate of plasma
cells is seen.34 In contrast with syphilis, there is little
endothelial cell proliferation or vascular obliteration.34
T pallidum can be identiﬁed in tissue sections using
Warthin-Starry or Levaditi silver stains. While T palli-
dum pertenue is found mainly in the epidermis, T palli-
dum pallidum is identiﬁed more in the dermis.35 Direct
and indirect immunoﬂuorescence and immunoperoxi-
dase tests using speciﬁc polyclonal antibodies to T pal-
lidum can also be used with histology specimens.36
Radiology
Bone involvement may be revealed by radiographs even
when clinical signs are absent (Figure 7).37
Treatment
Benzathine penicillin-G has been the mainstay of treat-
ment for yaws for over 60 years. Lower doses are used
compared to syphilis with a recommended dose of 0.6
MU for children (under 10) and 1.2 MU for older chil-
dren and adults. In a recent single-centre randomised
control trial, one dose of azithromycin 30mg/kg was
shown to be equivalent to penicillin in patients with
primary and secondary yaws, with a cure rate of
approximately 95%.38 No other treatment strategies
are supported by randomised control trials although
data from case series suggest oral penicillin can be
successful.9
Based on these ﬁndings, azithromycin is now central
to the WHO eradication plan for yaws, which aims to
employ community mass treatment in endemic regions.
WHO plan to have no further cases of active yaws
worldwide by 2017 and to conﬁrm eradication by
2020.39,40 Despite this optimism there are several bar-
riers to a successful eradication programme including a
lack of accurate epidemiological data from many coun-
tries where yaws is reported, the absence of dedicated
funding for eradication eﬀorts and a concern that
resistance to azithromycin, well described in syphilis,41
will emerge in yaws. Monitoring for this during the
eradication programme will be essential. This ambi-
tious plan will require considerable input from NGOs,
academic institutions and policy makers.
Response to treatment
Treponemes disappear from lesions within 8–10 hours
of treatment with penicillin. Skin lesions begin to heal
within 2–4 weeks (Figure 8). In patients with secondary
yaws, joint pains may begin to improve within as little
as 48 hours.42 Bone changes are reversible if treated
Figure 8. Primary yaws: healed Lesion. Copyright Michael
Marks.
6 International Journal of STD & AIDS 0(0)
 at London School of Hygiene and Tropical Med on April 1, 2015std.sagepub.comDownloaded from 
XML Template (2014) [3.9.2014–7:02pm] [1–8]
//blrnas3/cenpro/ApplicationFiles/Journals/SAGE/3B2/STDJ/Vol00000/140160/APPFile/SG-STDJ140160.3d (STD) [PREPRINTER stage]
early enough. Following successful treatment the RPR
declines and at 12 months up to 90% of individuals
have either a four-fold reduction in RPR or become
seronegative.43 Failure of skin lesions to heal or the
RPR to drop should be considered treatment failure
and an indication for repeat treatment. In endemic set-
tings treatment failure is more common in individuals
from higher prevalence communities.44 Whether this
represents true treatment failure or re-infection is
unclear.
The authors of a study in Papua New Guinea
reported failure of yaws treatment with penicillin,
which they attributed to bacterial resistance, although
no laboratory evidence of this was available.45
Conclusions
Yaws is still endemic in a number of countries world-
wide despite a signiﬁcant reduction in the number of
aﬀected individuals following mass treatment cam-
paigns in the middle of the twentieth century.
Clinicians need to be aware of the epidemiology and
manifestations of yaws, which should be considered in
the diﬀerential diagnosis of patients with reactive ser-
ology from endemic countries. Older individuals may
have acquired yaws in countries that are no longer
endemic. Routine testing cannot distinguish between
syphilis and yaws. Treatment strategies are similar for
the two diseases, although a lower dose of penicillin is
used in yaws. Given the limitations in distinguishing the
two diagnoses clinicians should consider treating for
venereal syphilis in patients with reactive serology with-
out a clear history of yaws. In this context it is import-
ant that the clinician carefully explains to the patient
and their partner that reactive serology alone is not
diagnostic of a sexually transmitted route of infection.
Development of near-patient and laboratory tests
speciﬁc for treponemal sub-species is long overdue.
We also need to know if yaws can be transmitted
from mother to child in utero and whether it can pro-
duce neurological and/or cardiovascular complications.
Given the prevalence of macrolide and azalide resist-
ance reported in T pallidum pallidum, it is important
that surveillance of treatment eﬃcacy is maintained in
planned yaws mass treatment campaigns.
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